Global Alzheimer's Drugs Market to Witness Rapid Growth owing to Growing Geriatric Population

A new market research report by Transparency Market Research presents a detailed analysis of the global Alzheimer’s drugs market. The research study, titled “Alzheimer's Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018,” talks about the market overview, market drivers and restraints, opportunities and challenges, current market trends, major geographical segments, product segmentation, and vendor analysis of the market. The research study further includes historical data and forecast figures with the help of charts, tables, and infographics along with strategic recommendations to guide the existing as well as new players in formulating their business strategies and policies effectively.

Browse Full Report:

Alzheimer’s disease is a progressive neurological disorder that affects the functioning of the brain resulting in neuron loss. The most common symptom in the early stages is a difficulty in remembering, leading to short-term memory loss. At present, the global Alzheimer’s market does not offer any definitive treatment in order to cure or prevent Alzheimer’s disease. The global market only offers Alzheimer’s drugs to inhibit the progression of the condition.

Patients having Alzheimer’s disease are mostly given neurotransmitters including cholinesterase inhibitors and memantine. These drugs help the patient by slowing the progression of the condition. In addition, they offer temporary relief from several common symptoms of Alzheimer’s such as depression, anxiety, insomnia, and agitation in some cases.

The global market for Alzheimer’s drugs has been divided on the basis of geography into North America, Asia Pacific, Europe, and Rest of the World. Among these regions, North America dominates the overall market, holding around a share of 50% in the global Alzheimer’s drugs market in 2011. This region is estimated to remain in the leading position in the forecast period. India, Russia, Australia, and China are projected to hold growth potential owing to their unmet medical needs.

The increasing geriatric population across the globe is another factor that is expected to augment the growth of the global Alzheimer’s drugs market. Thus, it is becoming imperative for market players to launch new drugs and effective treatments. Most of the market players are currently concentrating on several research and development activities that could potentially lead to breakthroughs. In addition, the global market for Alzheimer’s drugs will have to struggle with challenges including drug patent expiry.

Furthermore, the vendor analysis of the global Alzheimer’s drugs market has been discussed in the research report. The study provides insights into the company through a profile, inception details, product portfolio, financial overview, business policies, and mergers and acquisitions, if any. Some of the major players operating in the global Alzheimer’s drugs market are Forest Laboratories, Inc., Novartis AG, Pfizer Incorporated, H. Lundbeck A/S, and Eisai Co., Ltd.

Request For Report Brochure:

About Us:-
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us:-
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Back to home page